A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

Clinical trial NCT02645253 · COMPLETED

Trial details

NCT number: NCT02645253
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Chronic Obstructive Pulmonary Disease COPD

Start date: 2016-01-12
Primary completion: 2016-04-17
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.